01. Particulate antigen sampling, migratory and naïve T cell priming abilities of monocyte-derived phagocytes in Peyer’s patches. Camille Wagner (France)

02. Frequency of immature dual negative dendritic cells is altered in systemic lupus erythematosus. Preeti Gautam (India)

03. Differential regulation of human dendritic cell biology by Leishmania infantum and Leishmania braziliensis. Giulia Lopes (Brazil)

04. The role of Tyk2 in dendritic cells. Stephen Shoebridge (Austria)

05. Genome-wide analysis of dendritic cell differentiation. Ioanna Tiniakou (USA)

06. Characterizing the immunosuppressive functions and development factors of CD1c+CD14+ dendritic cells.BAnouk Becker (Netherlands)

07. Small intestine epithelial cells shape the identity and fate of dendritic cells. Claudia Rivera (France)

08. 28 parameters flow cytometry for a better definition of myeloid cells in tissues. Valentin Le Guen (France)

09. Tracking human intestinal monocyte differentiation through single cell RNA sequencing. Line Wulff (Denmark))

10. Exploring mononuclear phagocyte diversity in the human gut with single-cell sequencing and flow cytometry. Thomas Fenton (Denmark)

11. Dendritic cells pre-condition naive T cells to promote their proliferation and effector differentiation potential. Caroline Wrangel (Germany)

12. ICELLNET: reconstruction of intercellular communication networks using transcriptomic profiles. Floriane Noel (France)

13. Role of RUFY4 in autophagy and immunity. Jan Valecka (France)

14. Diversity of osteoclasts contributes to the modulation of their inflammatory effect and resorptive function. Claudine Blin-Wakkach (France)

15. Investigation in SCFA effect on function and plasticity of intestinal dendritic cells. Anna Andrusaite (United Kingdom)

16. Regulation of steady state dendritic cell migration. Vuk Cerovic (Germany)

17. Mononuclear phagocytes analysis in mesenteric lymph nodes reveals differences between ulcerative colitis and Crohn’s disease. Marika Sarfati (Canada)

18. Creating new mouse strains to selectively track plasmacytoid dendritic cells across tissues and monitor their functions. Michael Valente (France)

19. Differentiation pathways of monocyte-derived phagocytes in Peyer’s patches. Hugues Lelouard (France)

20. Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific. Paula Michea (France)

21. A gut microbiota-derived metabolite reroutes intestinal expansion of antigen presenting cells from circulating monocytes for enhancing anti-tumoral activity and survival in colorectal cancer. Camille Chauvin (France)

22. Skin dendritic cells progressively subvert the activation of pathogenic type-2 immunity upon epicutaneous allergen immunotherapy. Léo Laoubi (France)

23. Regulation of lung dendritic cell homeostasis by Epstein-Barr virus induced gene 2 (EBI2). Lili Zhang (Germany)

24. Characterisation of chicken FLT3+ XCR1+ conventional dendritic cells (cDC) highlights conservation and divergences in amniote cDC function and development. Adam Balic (United Kingdom)

25. STAT1 and Type I IFN signaling pathway regulates dendritic cell development during steady state and inflammation. Chien-Kuo Lee (Taiwan)

26. Effective cancer immunotherapy by natural mouse conventional type-1dendritic cells bearing dead tumor antigen. Stefanie K. Wculek (Spain)

27. Cytomegalovirus-encoded gamma-chemokine vXCL1 selectively activates XCR1expressed on CD4- dendritic cells. Sebastian Voigt (Germany)

28. Differential accumulation and activation of monocyte and dendritic cell subsets in inflamed synovial fluid discriminates between juvenile idiopathic arthritis and septic arthritis. Pascale Louis-Plence (France)

29. Extracellular release of antigen by dendritic cell regurgitation
promotes B-cell activation. Fatah Ouaaz (France)

30. CD103posCD11bneg dendritic cells are crucial for development of primary biliary cholangitis. Debby Reuveni (Israel)

31. Single-cell RNA-seq reveals a segregation pattern of expression of the immunoregulatory protein GILZ in precursors of human blood DCs. Véronique Godot (France)

32. Identification of a mononuclear phagocyte as the major source of IL-23 production in chronic plaque psoriatic skin. Heena Mehta (Canada)

33. Bioactive glass: antibacterial efficacy and dose dependent in vitro modulation of dendritic cells. Elisabeth Zinser (Germany)



35. Statins induce the anti-inflammatory mediator GILZ (glucocorticoid-induced leucine zipper) in macrophages. Rebecca Linnenberger (Germany)

34. C/EBPβ-dependency of alveolar macrophages. Dorothea Dörr (Germany)

37. Mapping the spatial distribution of colonic mononuclear phagocyte populations. Dorothée Berthold (United Kingdom)

36. Non-)canonical TYK2 – a monarch in signalling into chromatin? Anzhelika Karjalainen (Austria)

39. Characterization of tissue-resident and infiltrating macrophages in the resolution of inflammation. Peter Rappl (Germany)

38. Unraveling the layers of embryonic myelopoiesis. Laina Freyer (France)

41. Comparative transcriptional analysis of gut-associated regulatory factors on bone marrow-derived macrophages. Ian Prise (United Kingdom)

40. Identification of the red pulp macrophage niche in the mouse spleen. Alicia Bellomo (France)

43. Hypoxic macrophage derived oncostatin-M inhibits cardiac fibrosis. Hiroaki Semba (Japan)

42. MSR1 triggers JNK-mediated lipid-induced inflammation and promotes obesity-associated non-alcoholic fatty liver disease. Sine Kragh Petersen (Sweden)

45. MEFV/miR-326 axis involvement in human macrophage polarization. Isabelle Duroux-Richard (France)

44. Resolving the Kupffer cell niche. Johnny Bonnardel (Belgium)

47. Role of intestinal dendritic cells and macrophages in inflammatory bowel disease. Charles Caër (Sweden)

46. Aging associated immunosenecent phenotype of peripheral blood monocytes. Barbora Frankova (Czech Republic)

49. A single-cell RNA-seq atlas of intestinal mononuclear phagocytes. Maria Gomez (United Kingdom)

48. Adipose tissue macrophage specific deletion of SH2 domain-containing protein tyrosine phosphatase 1 (SHP-1) improves glucose homeostasis in obese insulin resistant model. Yadhu Sharma (India)

51. Long term maintenance of alveolar macrophage identity through massive ex vivo expansion in culture. Sethuraman Subramanian (France)

50. Unbiased analysis of the myeloid differentiation cascade using single-cell phenotyping and transcriptomics combined with lineage tracing. Joseph Pucella (USA)

53. Human mononuclear phagocyte kinetics in health and disease. Amit Patel (United Kingdom)

52. A macrophage-specific transcription enhancer sustains MHCII expression and antigen-presenting capacity. Cristina Lopez Rodriguez (Spain)

55. Transcriptional interplay during myelopoiesis. Nina Henning (Germany)

54. Development of human lung macrophages from fetal and adult progenitors in vivo. Tim Willinger (Sweden)

57. Fetal-derived macrophages dominate in adult mammary glands. Pia Rantakari (Finland)

56. Multilevel control of dendritic cell homeostasis by ADAM10-mediated ectodomain shedding. Ronald Backer (Germany)

59. Polymerase III transcription is necessary for T cell priming by dendritic cells. Philippe Pierre (France)

58. Diverse macrophage populations exist in postnatal ovaries. Heli Jokela (Finland)

61. Splenic CD169+ marginal zone macrophages directly cross-prime CD8+ T cells in vivo using a vacuolar processing pathway. François-Xavier Mauvais (France)

60. Crystalline silica impairs the efferocytosis ability of human and mouse macrophages. Valérie Lecureur (France)

63. Sex and age determine the heterogeneity, transcriptional identity and function of peritoneal macrophages. Stephen Jenkins (United Kingdom)

62. MHC-II expression on resident colonic macrophages is partially regulated by the microbiota. Joël Guillaume (Germany)

65. Lupus autoimmunity and metabolic parameters are exacerbated upon high fat diet-induced obesity due to TLR7 signalling. Lena Alexopoulou (France)

64. Microbial disruption drives metabolic rewiring in pulmonary macrophages and a dysregulated type 2 response in the lung. Mann Elizabeth (United Kingdom)

67. The fate and plasticity of inflammatory macrophages during peritonitis. Pieter Louwe (United Kingdom)

66. Heterogeneous macrophage responses to dead cell clearance during development and inflammation. Noelia Alonso Gonzalez (Germany)

69. In vitro generation of colonic inflammatory monocyte-like cells and their plasticity into colonic macrophages. Marwa Bsat (Canada)

68. A single wave of monocytes is sufficient to replenish the long-term Langerhans cell network after immune injury. Clare Bennett (United Kingdom)

68A. Epigenetic innate immune memory in hematopoietic stem cells. Bérangère de Laval (France)



71. UPR-induced modulation of DC functions involved in T cell-mediated immunity during T. gondii infection. Anaïs Poncet (France)

70. Modulation of the IL-6 signaling pathway in herpes simplex virus type-1-infected mature dendritic cells. Alexandra Düthorn (Germany)

73. Brucella abortus infection drives rapid macrophage disappearance reaction from the peritoneal cavity. Gonzalez Espinoza Gabriela (France)

72. T cell-dependent upregulation of arginase 1 in monocyte-derived cells accounts for chronic cutaneous leishmaniasis caused by Leishmania mexicana. Baplu Rai (Germany)

75. Common monocyte progenitors are novel effector cells in mycobacterial immunity. Anne Kathrin Lößlein (Germany)

74. CD14 turnover participates in regulation of inflammatory response in murine macrophages. Anna Ciesielska (Poland)

77. The fate and function of hepatic macrophages during parasitic infection. Mohamed Musrati (Belgium)

76. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection. Marion Delphin (France)

79. Role of transcription factors in peripheral blood monocyte responses to sepsis. Ivana Andrejcinova (Czech Republic)

78. Deciphering cell-to-cell communication in perturbed whole blood using single-cell RNA sequencing. Nico Reusch (Germany)

81. Upregulation of interleukin-4 induced Arginase1 leads to a more sufficient infection control in Salmonella typhimurium infected macrophages. Natascha Brigo (Austria)

80. First description of human innate response immunomodulation by uropathogenic escherichia coli (UPEC). Lopes Giulia (Brazil)

83. The role of STAT1 isoforms in macrophage priming by IFNγ. Mojoyinola Joanna Ola (Austria)

82. Mechanisms of HIV-1 transfer from T lymphocytes to macrophages. Christel Verollet (France)

85. Effect of antibody-dependent intracellular neutralization on antigen-presentation by dendritic cell. Patricia Ng (Singapore)

84. Expression of TCR, but not of CD3, on human macrophages is dependent on mycobacterium tuberculosis virulence. Ramon-Luing Lucero De Los Angeles (Mexico)

87. Functions of PERK in autoimmune diseases and endoplasmic reticulum stress. Julien Gigan (France)

86. STAT1 in myeloid cells promotes extramedullary haematopoiesis during MCMV infection and sterile inflammation. Bulat Tanja (Austria)

89. Dynamical modeling of human T helper cell differentiation. Camille Chauvin (France)

88. Tolerant DCs induced upon exposure to HTLV-1-infected T cells. Auriane Carcone (France)

91. Ly6Chi monocytes are key orchestrators of gammaherpesvirus lifecycle. Céline Maquet (Belgium)

90. M-CSF induced myeloid and NK cell differentiation cascade protects from CMV viremia during hematopoietic stem cell transplantation. Prashanth Kumar Kandalla (Germany)

93. Elucidating the role of SteA of Salmonella typhimurium in modulating host responses. Aakanksha Gulati (India)

92. Constitutive Siglec-1 expression by human dendritic cell precursors enables HIV-1 replication and transmission to activated CD4+ T cells. Nicolas Ruffin (France)

95. Helminth infection modifies the lung macrophage responses that is associated with early susceptibility to gammaherpesvirus concurrent infection in C57BL/6 mice. Benjamin G. Dewals (Belgium)

94. Human CD1c+ dendritic cells are refractory to BK polyomavirus but transmit it to human primary renal tubular epithelial cells and protect it from neutralization. Franck Halary (France)

97. Deciphering the role of polysialic acid in the macrophage response to Mycobacterium tuberculosis infection. Aurélien Boyancé (France)

96. Herpes simplex virus paralyzes dendritic cell migration. Linda Grosche (Germany)

99. Macrophage-B cell interactions in the inverted porcine lymph node and their response to porcine reproductive and respiratory syndrome virus. Nicolas Bertho (France)

98. Characterization of Rufy3 protein in dendritic cells: potential modulator of autophagy and immunity. Remy Char (France)

101. Deciphering activation pathways of CD64 on human neutrophils and CD169 on monocytes, application to bacterial versus viral infection diagnosis. Fabrice Malergue (France)

100. Na+-boosted antibacterial defense is dependent on HIF1A and NFAT5. Patrick Neubert (Germany)

103. A gammaherpesvirus infection blocks the functionality of type 2 innate lymphoid cells in the context of HDM-induced airway allergy. Laurent Gillet (Belgium)

102. A gammaherpesvirus licenses CD8+ T cells to protect the host
from pneumovirus-induced immunopathologies. Bénédicte Machiels (Belgium)



105. Impact of macrophages on lymphoid neogenesis in CNS inflammation. Linda Groeneweg (Germany)

104. CD83 expressed on dendritic cells and microglia controls inflammatory autoimmune responses in the periphery and the central nervous system. Andreas Wild (Germany)

107. IFNγ controls the monocyte to phagocyte transition during tissue inflammation. Ana Amorim (Switzerland)

106. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Kiavash Movahedi (Belgium)

109. Probing the role of microglia in relapsing-remitting EAE. Zhana Haimon (Israel)

108. Exploring myeloid cell heterogenicity in the resolution of surgery induced intestinal inflammation reveals neuroprotective role for ariginase-1 macrophages. Matteoli Gianluca (Belgium)

110. The effect of traditional Chinese medicine compounds in regulating dendritic cells underlying Parkinson’ disease. Allen Cheung (Hong Kong)



111. Dissecting dendritic cell sialic acid-mediated interactions in antitumor immunity. Jinyu Wang (Switzerland)

112. In vitro models for screening of immune modulating properties of drug candidates under immunosuppressed conditions seen in cancer. Gad Monika (Denmark)

113. TNF-RIPK3 axis is crucial for the Kupffer cell reduction associated with tumoral progression following partial hepatectomy. Jean-François Hastir (Belgium)

114. Differences in the effect of cisplatin on the transcriptional profile of tumor-associated macrophages of breast cancer and colon cancer in vitro. Irina Larionova (Russian Federation)

115. The association of chitinase-like protein YKL-39 with locoregional and distant metastases in human colorectal cancer. Patysheva Marina (Russian Federation)

116. Revisiting the role of type 1 conventional dendritic cells (cDC1) in cancer immunosurveillance. Raphaël Mattiuz (France)

117. Targeting dendritic cells with glycosylated liposome-based vaccines for modulation of the immune system. Aram De Haas (Netherlands)

118. Analysis at single cell level of the heterogeneity of tumor associated macrophage in triple negative breast cancer. Timperi Eleonora (France)

119. Circulating lymphocytes and dendritic cells populations and subpopulations in cutaneous melanoma. Ionescu Adina-Claudia (Romania)

120. Tumor-induced monocyte adhesion drives pre-metastatic niche formation. Seung Hyeok Seok (Republic of Korea)

121. Tumor-derived inflammation drives T cell fate. Pierre Bourdely (United Kingdom)

122. Tumor-infiltrating myeloid cells are conserved between human and mouse lung cancers. Camilla Engblom (Sweden)

123. The role of bone marrow macrophages in the HSC niche during leukaemia growth. Flora Birch (United Kingdom)

124. Analysis of the transcriptome of circulating Ly6C(hi) monocytes reveals JAM-A as a novel marker of tumor-induced monocyte reprogramming. Laoui Damya (Belgium)

125. Identification of specific tumor associated macrophage targets in human breast cancer. Cassetta Luca (United Kingdom)

126. CCL17 suppresses macrophage anti-tumor activity to promote tumor growth. Rebecca Metzger (Germany)

127. A paradoxical role for Flt3 ligand in tumor immune response reveals homeostatic control of NK and Treg cells by dendritic cells. Nicolas Cagnard (France)

128. BAD-LAMP influences TLR9 signaling zone in human plasmacytoid dendritic cell and contribute to triple negative breast cancer immune evasion. Leone Dario (France)

129. CCR8 as a novel biomarker for the specific targeting of a highly suppressive tumor infiltrating regulatory T cell subset. Jo Van Ginderachter (Belgium)

130. Polarization of TAMs to a pro-inflammatory phenotype by SPIONs as an adjuvant lung cancer therapy. Natalie Horvat (Germany)

131. In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategies. Aleks Murgaski (Belgium)

132. Reactivation of tumor associated macrophages via proprotein convertase 1/3 inhibition. Marie Duhamel (France)

133. Ganglioside-containing liposomes target antigen to splenic CD169+ macrophages and induce T cell responses via Batf3-dependent dendritic cells. Joanna Grabowska (Netherlands)

134. Impact of lactic acid on human macrophage polarization. Clément Adam (France)

135. Lysates of glioma cells, glioma-conditioned or normal astrocytes differently influence dendritic cell function. Ivan Chekhonin (Russian Federation)

136. Impact of tumor infiltration by DCs and other immune cells on patient survival. Guillaume Darrasse-Jeze (France)

137. Food-derived β-glucans enhance plasticity of M2 macrophages towards new phenotype characterized by production of T cell chemo-attractants. Priscilla De Graaff (Netherlands)

138. Development of a next generation immune checkpoint modulator towards the clinic; a humanized BTN3A antibody (ICT01) activating gamm9delta2 T cells. René Hoet (France)

139. Omental macrophages of embryonic origin promote metastatic spread of ovarian cancer. Anders Etzerodt (Denmark)

140. Metabolic re-programming of monocytes-macrophages in tumor settings regulates their pro-tumor functions. Subhra Kumar Biswas (India)



141. A potential role for Bmp in macrophage recruitment to injured muscle revealed by mass cytometry. Matthew Borok (France)

142. Understanding hepatic macrophage heterogeneity in acute liver injury. Anna Bujko (Belgium)

143. Monocyte driven immune response in experimental aortic valve stenosis.Christina Weisheit (Germany)

144. Immune-instructive polymers for modulating macrophage polarization and promotion of wound healing. Amir Ghaemmaghami (United Kingdom)

145. Functional Impact of macrophages during tissue repair and aging. Kémy Adé (France)